RBC Capital Downgrades Bio-Techne to Sector Perform, Raises Price Target to $73

Benzinga Newsdesk www.benzinga.com Negative 86.0%

Neg 86% Neu 0% Pos 0%

RBC Capital analyst Dan Leonard downgrades Bio-Techne (NASDAQ:TECH) from Outperform to Sector Perform and raises the price target from $62 to $73.